Learn more about the CT-388-104 Study testing the safety and effectiveness of a selective GLP-1/GIP investigational drug for those living with overweight or obesity with type 2 diabetes.
You may be able to join the CT-388-104 Study if you:
- Are 18 through 75 years old
- Have a body mass index (BMI) of 25 or above
- Have been diagnosed with type 2 diabetes
- Have tried to lose weight once or more through diet and exercise but without success
There are other requirements for taking part in this study. The study team will go over these with you.
If you qualify to join, you may receive at no cost:
- The investigational drug or placebo
- Close medical care and follow-up throughout the study
- Lifestyle management counseling
Contact us to find out more about the CT-388-104 Study:
Alex Rolling, CRC, RD
205-996-2689